genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2020
WuXi Biologics
Bioprocessing
AB2 Bio and WuXi Biologics Collaborate on Orphan Drug Manufacture
News
Vir Biotechnology, Biogen, and NIAID (with WuXi Biologics and Xencor)
Bioprocessing
Jacobs Wins Contract to Provide Construction Services for WuXi
A-Lists
Top 10 Immuno-Oncology Startups of 2018
Drug Discovery
WuXi, Lilly Partner to Develop Dyslipidemia Candidate in China
Bioprocessing
WuXi Chooses Philadelphia for New Cell Therapy Manufacturing Facility
Bioprocessing
WuXi Facility Gets FDA Thumbs-Up for API Production
Bioprocessing
WuXi Gets Started on New Philadelphia Cell Therapy Manufacturing Facility
Drug Discovery
WuXi PharmaTech and PRA Contribute to China’s Biopharma Boom
Bioprocessing
WuXi Opens cGMP Biologics Facility in China
1
2
3
4
Page 3 of 4
Scroll Up
Scroll Up
